Premium
The six‐minute walk test is a valuable measure of functional change following chemotherapy for AL (light‐chain) cardiac amyloidosis
Author(s) -
Decker Ilka,
Goodman Stacey A.,
Phillips Sharon E.,
Lenihan Daniel J.,
Cornell Robert F.
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14585
Subject(s) - medicine , al amyloidosis , bortezomib , cardiology , cardiac amyloidosis , chemotherapy , induction chemotherapy , multiple myeloma , amyloidosis , brain natriuretic peptide , troponin t , transplantation , heart failure , immunology , myocardial infarction , antibody , immunoglobulin light chain
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom